Executives

Prior to Covance, over a 25-year clinical research career, Dr. James A. Bannon has held various positions of increasing responsibility in operations and executive management at various businesses. He built his career by using his deep understanding of the drug approval process and his technical training to lead the operations group of the Corning Pharmaceuticals Periapproval business. In this position, he had overall global responsibility for the delivery of all aspects of projects including project management, monitoring, data management and safety reporting.

He consistently demonstrated his intense focus on client satisfaction leading to the delivery of high quality service and significant repeat business. In addition, he was responsible for improving the overall performance of the data management and safety group by the incorporation of leading edge technologies including optical character recognition, relational database management and web-based adverse event management and reporting. These enhancements led to consistently improved service delivery, performance and profitability.

In 1995, he became the General Manager of the Corning Pharmaceutical Services Periapproval business. Under his executive leadership the sales, revenue and operating margin doubled twice over an 8-year period. During this time, the business was recognized with the Houghton Quality Award. This award recognized the Corning business unit that successfully implemented and utilized the Total Quality System to drive both client and employee satisfaction. As a result of these quality systems, the Periapproval business unit achieved consistently high customer satisfaction and employee satisfaction ratings resulting in a significant increase in repeat business and low employee turnover.

Over his career, he has had oversight for research projects involving hundreds of products across a broad range of therapeutic areas and medical specialties. He is an experienced executive with a history of successful performance who understands both the technical and business aspects of the clinical research industry.

Prior to joining IndiPharm in early 2007, Dr. Brennan was Director of Clinical Pharmacology and Discovery Medicine at GlaxoSmithKline plc (GSK). At GSK, Dr. Brennan was responsible for coordinating all clinical activities for external partners within GSK’s Center of Excellence in External Drug Discovery (CEEDD). Prior to joining the CEEDD, Dr. Brennan was Director of Clinical Pharmacology within the MMPD CEEDD at GSK where he was responsible for the development of multiple compounds from pre-Candidate Selection through Proof of Concept. Before joining GSK, Dr. Brennan held clinical development positions of increasing responsibility at both Johnson & Johnson and Wyeth.

Dr. Brennan has extensive experience across all phases of clinical development, and across multiple therapeutic areas, including oncology, infectious diseases, immunology and critical care. He has led teams that have filed more than 10 Investigational New Drug Applications, as well as multiple New Drug and Supplemental New Drug Applications.

Dr. Brennan received his undergraduate Bachelor of Science Degree in Pharmacy from The Philadelphia College of Pharmacy and Science. He went on to study medicine at The Royal College of Surgeons in Ireland before receiving his Medical Degree from Temple University School of Medicine. He completed his residency in General Surgery at the Lankenau Hospital and Medical Research Center, and, after completing his fellowship in Advanced Minimally Invasive Surgery at the Minimally Invasive Surgical Training Institute (Baltimore, MD), he returned to join the staff at Lankenau, where he held a teaching appointment from Thomas Jefferson College of Medicine. While on the staff at Lankenau, Dr. Brennan also served as Surgical Residency Director.

As an entrepreneur, Mr. Limaye has established a variety of international organizations in a wide range of fields including energy efficiency, renewable energy, global climate change, information technology (IT), and business process outsourcing (BPO). Mr. Limaye is the founder and major shareholder in INTESCO-Asia limited, an energy services company, and Synergic India Private Limited, a solar integrator company. In addition, as principal of Yuvis, Inc., he helped establish ValueCAD Inc., an outsourcing company for architectural drawings, Medscribe, a medical transcription services company, and Epiance India Pvt. Ltd. (formerly Guru Computers), a software company.

Most of these ventures have involved the establishment of a U.S.-based organization for client interface and client services combined with an Indian operation to execute projects and programs efficiently and effectively thereby providing clients global quality services with a local U.S. interface at a substantially lower cost than would be available in developed countries.

After successfully implementing this business model in the fields of renewable energy, energy services, IT and BPO, Mr. Limaye created IndiPharm for effectively outsourcing clinical trials to India for Pharma companies, thereby obtaining the timing and cost savings available in India.

Mr. Limaye earned his Bachelor of Technology degree from one of the premier technology institutions in the world, The Indian Institute of Technology (IIT), Bombay, where he graduated #1 in his class and received the prestigious President of India Gold Medal. He earned his M.S. from Cornell University and has completed his Ph. D. candidacy examination in international business from the Wharton School, University of Pennsylvania. Mr. Limaye has published six books and has presented over 50 technical papers at national and international conferences.

During his 20-year career, Mr. McBean has experienced clinical development from varied perspectives. He’s worked for large pharmaceutical, biotechnology and contract research organizations in roles of increasing responsibilities directing, implementing and managing various phase II-IV global development programs in the following indications: Cardiovascular, Dermatology, Endocrinology, Infectious Diseases, Oncology, Pulmonology, Urology, Vaccines and Medical Devices in adult and pediatric populations.

He has served in roles with a CRO as Director, Multi-Center Research (Dermatology - PRACS, U.S.) in biotechnology as Associate Director, Clinical Operations (Vaccines – MedImmune, U.S.), and in big-pharma as Assistant Director, Clinical Operations (Cardiovascular & Urology – GLAXOSMITHKLINE, U.S.), Senior Project Manager, Clinical Development and Senior Clinical Scientist (Anti-infectives, Anti-virals & Tropicals Asia-Pacific – GLAXOSMITHKLINE, Singapore), Clinical Investigation Scientist (SMITHKLINE BEECHAM INTERNATIONAL, Brentford, UK) and as Senior Analytical Development Scientist (SMITHKLINE BEECHAM, Crawley, UK) and early in in his career as Assistant Scientific Officer (Laboratory of Government Chemist, Teddington, UK).

Mr. McBean received his undergraduate Bachelor of Science in Chemistry from Kingston University, Thames, UK and went on to Thames Valley University, Slough, UK to receive his Postgraduate Diploma in Information Systems.

He is a committee member of the Drug Information Association (DIA) India Advisory Committee. Also, a member of the Indian Society of Clinical Research and the Project Management Institute’s Queensland chapter.

She has worked as a consultant in pharmacovigilance providing pharmacovigilance expertise, project management and audit and inspection readiness activities. She is experienced in change management, process efficiencies and organizational effectiveness.

Angela was formerly Vice President of Drug Safety Surveillance at Pfizer Inc. where she successfully developed and led 12 therapeutic area teams and supporting functions for the management of adverse event reporting for human health including all phases of a product life cycle (drugs, vaccines and devices). She led these activities using a combination model of 360 in-house staff at four global locations US, Europe and Asia. In addition she developed and managed 3 off-shored safety processing vendor sites in India as well as one outsourced group in the US.

Angela gained her RN from Nottingham University, UK; a Diploma in Pharmacovigilance from Hertfordshire University, UK and an MBA from the Zicklin School of Business, Baruch College in New York, USA.